UMORS of the central nervous system represent a risk factor for the development of affective disorders such as depression, anxiety, and panic attacks. 11, 16, 17 In particular, depression is common in patients with central nervous system tumors, 23 and the prevalence of depressive symptoms in these patients can vary from 15 to 38%. 4, 18 Furthermore, recently it has been found that preoperative depression represents a prognostic factor for worse survival rates among patients affected by glioblastoma 13 and low-grade glioma.
treatment was performed at the Department of Neurosurgery of "Casa Sollievo della Sofferenza" Hospital, San Giovanni Rotondo, Italy.
Radiological diagnosis of the brain tumors was made using computed tomography or magnetic resonance imaging; histological grading was attributed according to the WHO classification. 20 The tumors were divided into the following classes: Grade I-II gliomas, Grade III-IV gliomas, and benign tumors (meningiomas, pituitary adenomas, and vestibular schwannomas). 12 A cognitive assessment was performed to verify that patients could understand the test procedures. Cognitive impairment was assessed using the 10-item SPMSQ. 19 The SPMSQ is a widely used, valid, reliable, 10-item questionnaire designed to evaluate orientation, memory, and concentration. The score is evaluated in terms of errors. Patients with 5 or more errors on the SPMSQ were considered to have moderate to severe impairment, and patients with 3-4 errors were considered to have mild cognitive impairment; patients with 0, 1, or 2 errors were classified as having no cognitive impairment. The SPMSQ has a specificity Ͼ 90% and sensitivity of 50-82%. 29 The SPMSQs were administered before surgery and at 1, 3, 6, and 12 months after surgery.
Exclusion criteria were as follows: the presence of previous psychiatric disease; alteration of the levels of hypothalamic-pituitary-adrenocortical axis hormones in serum; age Ͻ 18 years; and the presence of severe clinical signs of neurological deficits and/or cognitive impairment with an SPMSQ score Ͼ 2. Patients affected by neurological and/or cognitive impairment before or after surgery were excluded to avoid bias related to the reduction of the individual's ability to cooperate with the psychometric test. Written informed consent was obtained from all participants.
Among 114 patients initially enrolled in the study, 10 (8.8%; 3 men and 7 women) died during follow-up, 5 (4.4%; 3 men and 2 women) did not show adherence to the psychometric evaluation at follow-up, 12 (10.5%; 5 men and 7 women) showed a cognitive impairment with SPMSQ score Ͼ 2 at follow-up, and 15 (13.2%; 5 men and 10 women) showed severe neurological deficits; all of these patients were excluded from the statistical evaluation. A sample of 72 patients, 31 men (43.1%) and 41 women (56.9%) whose mean age was 45.5 Ϯ 17.3 years (range 20-78 years) were considered for the final statistical analysis.
Psychological Assessment
All the participants were given a questionnaire seeking information on their level of education, socioeconomic, and marital status (Table 1) , and containing 2 different selfrating psychometric tests: 1 for the state and trait anxiety and the other for current depression.
State and trait anxiety was assessed using the STAI, made up of 2 axes (y1 for state anxiety and y2 for trait anxiety), both consisting of 20 multiple-choice items; each item has a score from 1 to 4 so that the total point score of y1 and y2 axes can range from 20 to 80. 24 This test was selected on the basis of its simplicity, validity, and reliability. 7, 10 In particular, the STAI test permits a distinction between existing anxiety and predisposition to an anxious reaction as a personality characteristic, as previously described. 2 This theory is based on the conceptual distinction between anxiety as a transitory state and anxiety as a relatively stable personality trait. State anxiety is conceptualized as an emotive state characterized by subjective feelings perceived on a conscious level, such as apprehension and tension, which vary with time; anxiety as a trait refers to individuals with a continuous disposition toward anxiety. 1 The patients we evaluated were grouped as high-anxious and low-anxious, and a value of 40 was used to distinguish between the 2 groups, according to the classifications developed by Spielberger et al. 24 and by Weinstein.
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The presence of depression was assessed using the Zung SDS. 30 This scale contains 20 multiple-choice items with a score from 1 to 4 each, so that a total point score of Ͼ 49 is considered high. 9 The point score is based on the frequency of depressive symptoms; minor symptoms that occur frequently therefore have a high score. This test constitutes an effective instrument in screening for depression in a clinical setting, 21 and its positive predictive value for a diagnosis of depression is between 88.7 and 92.3%.
14 The STAI and Zung SDS were administered before surgical treatment and 1, 3, 6, and 12 months after surgery.
Statistical Analysis
Continuous data with normal distribution are given as the mean Ϯ standard deviation, and categorical data are expressed as percentages. The normality of data distribution was tested by the Kolmogorov-Smirnov test. The group was examined using the Cochrane Q procedure test for multiple related samples to evaluate how STAI y1, STAI y2, and Zung SDS parameters change at follow-up. The variables with a probability value Ͻ 0.10 at univariate analysis were entered in a multivariate logistic regression anal- ysis to identify the independent predictors of Zung SDS positivity at 1 and 3 months postsurgery. Categorical data were analyzed using the chi-square test or the Fisher exact test as appropriate. A probability value Ͻ 0.05 was considered significant. The data were statistically analyzed using SPSS version 13.0 software (SPSS Inc.).
Results
Sociodemographic characteristics of the sample, the histological type, and localization of the brain tumors are reported in Table 1 . Figure 1 shows the percentage of patients affected by state anxiety, trait anxiety, and current depression before surgery and at the different follow-up intervals. Before surgical treatment, a high percentage of patients affected by state anxiety (62.5%) and trait anxiety (50%) were found among the enrolled patients, whereas the percentage of patients showing current depression was relatively low (9.7%). During the follow-up period, however, there was no significant variation in the percentage of patients with state anxiety (p = 0.416) and trait anxiety (p = 0.7), whereas a significant increase in the percentage of those with current depression was found (p Ͻ 0.0001). The percentage of patients with current depression significantly increased at 1 month (p = 0.002) and 3 months (p = 0.039) after surgical treatment, and it continued to increase at 6 months and 1 year after surgical treatment, although without reaching statistical significance (p = 0.72 and p = 0.45, respectively; see also Table 2 ). The number of patients affected by state anxiety, trait anxiety, and current depression before surgery and at the different follow-up intervals is reported in Table 2 .
At analysis, the presence of current depression at 1 month postsurgery was directly correlated to female sex (p = 0.007), trait anxiety (p = 0.0009), and current depression (p = 0.007) before surgery, and with state anxiety (p = 0.003) and trait anxiety (p Ͻ 0.0001) at 1 month postsurgery. The logistic regression showed that at 1 month after brain surgery the main determinant of current depression was the presence of trait anxiety (p Ͻ 0.0001). The presence of current depression at 3 months postsurgery was directly correlated to female sex (p = 0.001), trait anxiety before surgery (p = 0.003), state anxiety (p Ͻ 0.0001), trait anxiety (p Ͻ 0.001), and current depression (p Ͻ 0.0001) at 1 month postsurgery, and state anxiety (p Ͻ 0.0001) and trait anxiety (p Ͻ 0.0001) at 3 months postsurgery. The logistic regression showed that at 3 months after brain surgery the main determinant of current depression was the presence of current depression at 1 month after surgery (p Ͻ 0.0001) and state anxiety at 3 months after surgery (p Ͻ 0.0001).
When we evaluated patients divided by sex, no significant variation in the percentage of state and trait anxiety was found in either women or men, whereas the percentage of patients with current depression significantly increased during the follow-up period in both women and men (Table  3 ). In women compared with men, however, a significantly higher percentage of state anxiety, trait anxiety, and current depression was found before surgery and at the different follow-up intervals (Table 4) 
Discussion
The presence of affective disorders such as anxiety and depression is common in patients affected by primary brain tumors before surgery. 18, 26 However, data concerning affective disorders after surgery are still controversial. In particular, although some authors found a regression of anxiety 16, 20 and depression 17, 20 after surgery, others showed an increase of the depression at these patients' follow-up evaluations. 14 Nevertheless, it is difficult to differentiate the role played by the neurophysiological effects of the tumor per se and the role played by the patient's knowledge of being affected by a cerebral disease. Moreover, most of the studies assessed anxiety and depression only a few times during the follow-up after surgery.
In the present longitudinal study, state and trait anxiety and current depression were evaluated before and after brain surgery in several testing sessions in a cohort of patients affected by primary brain tumors. A high percentage of patients affected by state and trait anxiety was found among the enrolled patients before brain surgery. These results could be due to a psychological reaction to several factors (such as the diagnosis of a brain lesion; 20 the fear of surgical intervention and/or anesthesia; or the risk of death, coma, or neurological and physical deficits after surgery) other than to the hospitalization. 27 During the follow-up period, although state and trait anxiety did not significantly change in our sample, an increase in percentage of current depression was found, particularly at 1 and 3 months after the surgical procedure, although it tended to increase also at 6 months and 1 year after surgery. These data are in line with recent findings by Litofsky and coworkers, 13 who showed increased levels of depression at 6 months after tumor surgery.
At univariate analysis, several factors showed a direct correlation with the increase of current depression at 1 and 3 months after surgery; these were female sex, trait anxiety, and current depression before surgery. However, at the logistic regression the main determinant for the increased current depression was the presence of anxiety, as a trait before surgery and as a state after surgery. Also, the presence of current depression at 1 month postsurgery was the main determinant of current depression during the remaining follow-up period. These data could indicate that patients with brain tumors who exhibit anxiety should be strictly followed after surgery because of the risk of developing current depression in a short time, with its tendency to increase. 6 The relationship between sex and affective disorders in such patients is still controversial. Some authors found no sex difference, 4, 15, 18 whereas others showed high levels of anxiety 20 or depression 15 in female patients before surgery, and a high risk for depression and for a decrease of quality of life at 1 year after surgery. 3, 15 According to these last data, our findings showed that state anxiety, trait anxiety, and current depression are present in a significantly higher percentage of female patients compared with male patients both before and after neurosurgery. Moreover, our data are supported by epidemiological evidence showing that the prevalence of depression in female patients is approximately twice that in male individuals in the general population, 22 and by data showing that, among patients with cardiac diseases, females show higher levels of anxiety and depression, coupled with worse psychological profiles. 28 There were no significant differences in anxiety and showed high scores of anxiety and depression in patients affected by meningiomas compared with patients affected by malignant tumors, our data are in line with the studies by Mainio and coworkers. 15, 17 Our data could indicate that the diagnosis of cerebral tumor itself and the fear of both the surgical intervention and the recurrence risk, more than the histological type, are able to affect the psychological reaction of the patients.
It has been reported that steroid therapy and radiotherapy and/or chemotherapy can influence mood. 8, 26 In our study, however, patients treated with steroid therapy, radiotherapy, and/or chemotherapy in addition to surgery were only the ones affected by high-grade glioma, whereas the others did not receive steroids, radiotherapy, and/or chemotherapy. Because no differences were found in current depression between these 2 groups, we can assume that in our patients current depression was not influenced by radiotherapy and/or chemotherapy. Our data are in agreement with those of Litofsky et al., 13 who recently showed no relationship between depression, steroid treatments, and radiotherapy and/or chemotherapy in patients affected by highgrade glioma.
No statistical differences were found when comparing the brain tumor's laterality with occurrence of anxiety and depression. These data are in contrast with those of Mainio and coworkers, 16 who showed high scores of anxiety in patients with a brain tumor in the right hemisphere and a rapid decline of anxiety levels after resection of the tumor. This apparent discrepancy could be due to the different samples evaluated and to the different psychometric scales used. Future studies are needed to shed light on this point.
Usually the psychological experience of being affected by a brain tumor is not adequately taken into account. Patients with brain tumors frequently exhibit affective disorders such as anxiety, depression, or panic, and these symptoms often continue to be present after surgical treatment. 5 During the diagnostic period, the physician-patient interaction is generally focused on issues such as diagnosis of the tumor, treatment options, long-term prognosis, and neurological assessment, but evaluation of psychological assessment seems not to have a high priority. Symptoms of depression and anxiety often mimic those commonly found in patients with brain tumors (that is, tiredness and fatigue), but usually the neurosurgeon focuses his or her attention only on the organic features. 26 For these reasons the psychometric evaluation gains great importance in the global evaluation of patients affected by brain tumors, to recognize and treat psychological disorders quickly, thus improving the quality of life of these patients. In this context, our data led us to hypothesize a potential beneficial role of antianxiety and/or antidepressant drug therapy and/or psychological support counseling in patients affected by primary brain tumors. Further studies are needed to evaluate the most effective treatment for psychological disorders in these patients
Conclusions
Patients suffering from brain tumors frequently show affective disorders. After brain surgery a depressive state can develop. Psychometric assessments could be useful in these patients to recognize psychological disorders quickly. 
